Therapeutic Classification in Drug Compendia at Product Launch
Industry
Drug Compendia
Problem
A brand pharmaceutical manufacturer had a forthcoming product with the same general mechanism of action as current on-market agents. However, the product differed in its indication and expected usage. The client was seeking assistance in differentiating their product from competitors within the drug pricing compendia, in the hopes of being favorably viewed by payers.
PHSL Solutions
PHSL reviewed the draft Prescribing Information of the manufacturer’s forthcoming product. PHSL then analyzed and identified current therapeutic classifications available in the leading drug pricing compendia databases and worked with the manufacturer to proactively request a unique categorization for the drug.
Results
The manufacturer was able to gain a unique Enhanced Therapeutic Classification (ETC) category in FDB, differentiating them from their competitors.